within Pharmacolibrary.Drugs.N_NervousSystem.N02A_Opioids.N02AC54_DextropropoxypheneCombin;

model DextropropoxypheneCombin
  extends Pharmacolibrary.Pharmacokinetic.Models.PK_1C_enteral(
    weight = 70,
    F = 0.5,
    Cl = 5.0555555555555555e-06,
    adminDuration = 600,
    adminMass = 65 / 1000000,
    adminCount = 1,
    Vd = 0.016,
    Cmin = 0.001,
    Cmax = 0.01,
    Ctox_peak = 0.02,
    Ctox_trough = 0.01,
    ka = 0.010666666666666666,
    Tlag = 10.200000000000001);

  annotation (Documentation(
    info       = "<html><body><table><tr><td>name:</td><td>DextropropoxypheneCombinationsExclPsycholeptics</td></tr><tr><td>ATC code:</td><td>N02AC54</td></tr><td>route:</td><td>oral</td></tr>
    <tr><td>compartments:</td><td>1</td></tr>
    <tr><td>dosage:</td><td>65</td><td>mg</td></tr>
    <tr><td>volume of distribution:</td><td>16</td><td>L</td></tr>
    <tr><td>clearance:</td><td>0.26</td><td>L/h/kg</td></tr>
    <tr><td colspan='3'>other parameters in model implementation</td></tr>
    </table><p>Dextropropoxyphene is a mild opioid analgesic previously used for the treatment of mild to moderate pain, often in combination with other analgesics such as acetaminophen. Due to safety concerns including risk of fatal overdose and cardiac toxicity, it has been withdrawn or banned in many countries.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters derived from studies on healthy adult volunteers using typical oral combination formulations excluding psycholeptics.</p><h4>References</h4><ol></ol></body></html>",
    revisions  = "<html><body><ul><li>10/2026 Pharmacolibrary 26.09: model of Drugs.ATC.N.N02AC54 folded in (Drugs.ATC removed)</li><li>06/2025 Tomas Kulhanek, generated model from data extracted from PUBMED, DrugBank and LLM(GPT4.1)</li></ul></body></html>",
    experiment (StartTime = 0, StopTime = 86400, Tolerance = 1e-9, Interval = 1)
  ));
    
end DextropropoxypheneCombin;
